TrialBrain communications2025

An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis.

Ruben P A van Eijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.